2m 2m 2m 2m 2m 2m 2m
Genmab (GNMSF)
OTC
$250.00+$0.72 (+0.29%)
Price as of Jun 22, 2026- N/AMarket Cap
- 18.43%1-Year Change
- BiotechnologyIndustry
Genmab (GNMSF)
$250.00+$0.72 (+0.29%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$250.00
$250.00
$250.00
1-Year Range
$198.51
$352.00
$250.00
Latest Close$250.00
Change
+$0.72 (+0.29%)
Volume10
Information as of 06/22/2026
Company Profile
GENMAB A/S DKK
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
GENMAB A/S DKK
Key Executives
- Jan van de Winkel
- Rayne Waller
- Gregory David Emil Mueller
- Tahamtan Ahmadi
- Judith V. Klimovsky
Current Ownership Distribution
- Other55.7M (90.77%)
- Mutual Funds5.6M (9.19%)
- Institutions22,840 (0.04%)
- Insiders0 (0.00%)